You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Respiratory conditions
  5. Chronic obstructive pulmonary disease

Roflumilast for treating chronic obstructive pulmonary disease

  • Technology appraisal guidance
  • Reference number: TA461
  • Published:  26 July 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Final appraisal determination
  2. Draft guidance
  3. Invitation to participate

History

Documents created during the development process.

Final appraisal determination

  • Final appraisal determination

  • Committee papers (PDF 1.53 MB)

    Published:
    22 June 2017
  • Final appraisal determination document (PDF 398 KB)

    Published:
    22 June 2017

Draft guidance

  • Draft guidance

  • Appraisal consultation document (PDF 433 KB)

    Published:
    07 February 2017
  • Committee papers (PDF 17.55 MB)

    Published:
    07 February 2017
  • Appraisal consultation document Clinical Effectivenss Presentation Slides (PDF 387 KB)

    Published:
    07 February 2017
  • Appraisal consultation document Cost Effectiveness Presentation Slides (PDF 408 KB)

    Published:
    07 February 2017

Invitation to participate

  • Final scope (PDF 103 KB)

    Published:
    08 August 2016
  • Final matrix (PDF 37 KB)

    Published:
    08 August 2016
  • NICE's response to comments on the draft scope and provisional matrix (PDF 209 KB)

    Published:
    08 August 2016
  • Equality impact assessment (Scoping) (PDF 119 KB)

    Published:
    08 August 2016
Back to top